iShares International Treasury Bond ETF vs GeneDx Holdings Corp — how do they compare? iShares International Treasury Bond ETF trades at $41.25, while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). Which is the better fit depends on your goals.
| IGOV | WGS | |
|---|---|---|
52-Week High | $43.09 | $167.51 |
52-Week Low | $40.35 | $34.51 |
Market Cap | — | $2.44B |
Sector | — | Technology |
Enterprise Value | — | $2.48B |
Signals from Pluang's Aura AI — not financial advice
IGOV, an iShares International Treasury Bond ETF trading as a US stock, is priced at $41.19 with no recent change. Technical indicators show a bullish trend from moving averages, while oscillators are neutral. The asset faces pressure from global inflationary trends and rising interest rates, as highlighted in recent financial news.
The outlook for IGOV is cautious due to its high duration exposure amplifying risks from global rate hikes. Investment opportunities are limited by macroeconomic headwinds, with key risks including capital loss potential from prolonged energy issues and geopolitical tensions affecting international bond markets.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Trailing returns across standard periods
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →